CRH Medical Corp (TSE:CRH)’s stock price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $2.81 and traded as high as $3.10. CRH Medical shares last traded at $3.08, with a volume of 554,732 shares traded.
A number of equities research analysts recently issued reports on the stock. Royal Bank of Canada decreased their price objective on shares of CRH Medical from C$6.50 to C$4.75 and set an “outperform” rating for the company in a report on Friday, March 13th. Beacon Securities cut shares of CRH Medical from a “buy” rating to a “hold” rating in a report on Thursday, May 14th. Finally, National Bank Financial decreased their price objective on shares of CRH Medical from C$4.25 to C$4.00 and set an “outperform” rating for the company in a report on Monday, May 4th.
The company has a debt-to-equity ratio of 57.85, a current ratio of 2.83 and a quick ratio of 2.74. The stock’s fifty day moving average is C$2.82 and its 200-day moving average is C$3.83. The stock has a market capitalization of $213.26 million and a P/E ratio of 53.97.
About CRH Medical (TSE:CRH)
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures.
Featured Story: What is total return in investing?
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.